The benefits of undertaking your trial with us in Australia include an:
Australia’s Regulatory Process
Studies approved in 4-5 weeks of submission, No IND application required, and data outputs meet global FDA and EMA standards
Research & Development (R&D) Incentive Scheme
Companies conducting Clinical Trials in Australia may be eligible for Australia’s R&D incentive Scheme, with refunds of up to USD 45c in every USD $1 spent in R&D.